Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

EMD-221963, a representative NHE-3 inhibitor from Merck KGaA

May 17, 2001

NDA filed in Hong Kong for NexMed's ED treatment

May 16, 2001

Tanabe Seiyaku issued patent covering new PDE5 inhibitors and their use

May 11, 2001

Watson seeks FDA approval for overactive bladder treatment

May 4, 2001

Kissei and Daiichi will codevelop and comarket BPH Rx in Japan

May 3, 2001

Cialis demonstrates extended duration in clinical trials in ED

May 3, 2001

Tolterodine ER shows improved efficacy and safety

May 2, 2001

Senetek's Invicorp well tolerated for ED in hypertensive patients

April 25, 2001

Senetek's Invicorp safe and effective for severe ED in diabetics

April 24, 2001

Newly synthesized PDE5 inhibitor is more potent and selective than sildenafil

April 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...